A Preliminary Exploratory Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants Aged 18 Years and Over in China

NCT05547256 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2

Interventions

BIOLOGICAL: COVID-19 Variant (Omicron BA.5) mRNA Vaccine Low dose
BIOLOGICAL: COVID-19 Variant (Omicron BA.5) mRNA Vaccine High dose
DRUG: Placebo

Sponsor

AIM Vaccine Co., Ltd.

Collaborators

[object Object]
[object Object]